In the field of recombinant antibodies and proteins, Crucell is actively seeking partners at various stages of product development including discovery, generation and development, as well as distribution and marketing. The evaluation of synergy between antibodies and small molecule drugs, e.g. anti-virals and antibiotics, is also of interest.

For more information on partnering opportunities in relation to proteins and antibodies, please visit the Partners section of our website.